Author

Ravinder Manchal

Observed names: M. Ravinder, Manchal , Ravinder, Manchal, Ravinder, R. Manchal

Observed institution: Chaitanya

ORCID: 0000-0001-9577-4014

Observed ORCIDs: 0000-0001-9577-4014, 0000-0002-0588-5077

OpenAlex ID: A5022341873

Fused benzo[1,3]thiazine-1,2,3-triazole hybrids: Microwave-assisted one-pot synthesis, in vitro antibacterial, antibiofilm, and in silico ADME studies

2021 · E. Ramya Sucharitha, Thupurani Murali Krishna, et al. · Bioorganic & Medicinal Chemistry Letters · 74

Synthesis and biological evaluation of novel [1,2,3]triazolo-pyrrolo[1,2-a]pyrido[4,3-d]pyrimidines as EGFR targeting anticancer agents

2022 · Sandhya Rani Bandi, Natte Kavitha, et al. · Journal of Molecular Structure · 52

Synthesis and biological evaluation of coumarine-imidazo[1,2-c][1,2,3]triazoles: PEG-400 mediated one-pot reaction under ultrasonic irradiation

2023 · Rajkumar Samala, Satheesh Kumar Nukala, et al. · Journal of Molecular Structure · 44

Synthesis of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-1,2,3-triazoles as potent EGFR targeting anti-breast cancer agents

2024 · Swathi Chirra, Ramesh Gondru, et al. · Journal of Molecular Structure · 39

Synthesis of new morpholine-benzimidazole-pyrazole hybrids as tubulin polymerization inhibiting anticancer agents

2022 · Ravikumar Reddy Sagam, Satheesh Kumar Nukala, et al. · Journal of Molecular Structure · 38

In‐vitro Anticancer and Molecular Docking Studies of 4‐Azaindole‐1,2,4‐Oxadiazole Hybrids

2021 · Ravikumar Reddy Sagam, Satheesh Kumar Nukala, et al. · ChemistrySelect · 32

Design, Synthesis, and Molecular Docking Studies of Some New Quinoxaline Derivatives as EGFR Targeting Agents

2022 · Vinitha Badithapuram, Satheesh Kumar Nukala, et al. · Russian Journal of Bioorganic Chemistry · 20

PDF

Synthesis of Quinoline‐Thiazolidine‐2,4‐dione Coupled Pyrazoles as in vitro EGFR Targeting Anti‐Breast Cancer Agents and Their in silico Studies

2023 · Mallikarjuna Bangaru, Satheesh Kumar Nukala, et al. · ChemistrySelect · 18

PDF

Design and Synthesis of Some Novel Aromatic Amide Derivatives of Nilutamide as In Vitro Anticancer Agents

2020 · Narasimha Swamy Thirukovela, Satheesh Kumar Nukala, et al. · ChemistrySelect · 17

Design and Synthesis of Some New Indole‐piperazine‐1,2,3‐triazole Conjugates; In Vitro Anticancer, Molecular Docking, and ADMET Studies

2025 · Veeraboina Lingaswamy, Satheesh Kumar Nukala, et al. · ChemistrySelect · 15

PDF

Design and synthesis of some new imidazole-morpholine-1,2,4-oxadiazole hybrids as EGFR targeting in vitro anti-breast cancer agents

2024 · Praveen kumar Kannekanti, Satheesh Kumar Nukala, et al. · Journal of Molecular Structure · 15

One-pot synthesis of some new regioselective 4β-pyrazolepodophyllotoxins as DNA topoisomerase-II targeting anticancer agents

2021 · Rajkumar Nagavath, Satheesh Kumar Nukala, et al. · Journal of Molecular Structure · 14

New Ag(I)−NHC/TBHP System for Oxidative Coupling of α‐Hydroxy Acetophenones with Amines: A Base‐Free and Efficient Synthesis of α‐Ketoamides in Water

2023 · Mohammad Muqeed, Ravinder Manchal, et al. · Asian Journal of Organic Chemistry · 12

PDF

Design and Synthesis of Some New N -(Thiazol-2-yl) Benzamides of Quinoxaline as DNA Topoisomerase II Targeting Anticancer Agents and ADMET

2022 · Yellaiah Bonakolluru, Satheesh Kumar Nukala, et al. · Polycyclic aromatic compounds · 11

Design, synthesis, in silico molecular docking, and ADMET studies of quinoxaline‐isoxazole‐piperazine conjugates as EGFR‐ targeting agents

2024 · Mohammad Imtiyaz Ali, Narasimha Swamy Thirukovela, et al. · Chemical Biology & Drug Design · 10

PDF

New quinoxaline‐piperazine‐oxazole conjugates: Synthesis, in vitro anticancer, in silico ADMET, and molecular docking studies

2024 · Mohammad Ferazoddin, Siddhartha Marupati, et al. · Journal of Heterocyclic Chemistry · 10

PDF

Synthesis of Novel 1,2,3-Triazole Derivatives of Tolbutamide and Evaluation of Their Antibacterial, Antioxidant, and DPP-4 Inhibitory Activity

2022 · Swathi Chirra, Sirassu Narsimha, et al. · Russian Journal of Bioorganic Chemistry · 10

Design, Synthesis, and Anti-Proliferative Activity of Quinoxaline Linked 1,2,4-Oxadiazole Hybrids

2022 · Vinitha Badithapuram, Satheesh Kumar Nukala, et al. · Russian Journal of General Chemistry · 10

Synthesis of Amide Derivatives as Tubulin Polymerization Inhibiting Antiproliferative Agents

2023 · Praveen kumar Kannekanti, Satheesh Kumar Nukala, et al. · ChemistrySelect · 9

Design, synthesis and biological evaluation of isoxazole bearing 1, 3-oxazole-1, 3, 4-oxadiazole derivatives as anticancer agents

2022 · Arun Kumar Lingala, Kiran Kumar Murahari, et al. · Chemical Data Collections · 8

Imidazole-Thiazolidine-2,4-dione Conjugated 1,2,3-Triazole Derivatives as Tubulin Aiming Antiproliferative Agents

2023 · Ashwini Nagaraju, Satheesh Kumar Nukala, et al. · Russian Journal of Bioorganic Chemistry · 7

Design, synthesis and anticancer evaluation of isoxazole fused thiazole-oxazole derivatives

2022 · Arun Kumar Lingala, Thirupathi Mothe, et al. · Chemical Data Collections · 7

Synthesis of Some New Indole-1,3,4-Oxadiazole Hybrids as Tubulin Polymerization Inhibitors

2022 · Sunitha Boda, Satheesh Kumar Nukala, et al. · Russian Journal of Bioorganic Chemistry · 6

Synthesis and in-vitro anti-EGFR screening of new 1,2,3-triazole-benzimidazole hybrids and insilico studies

2025 · Advaitha Vanaparthy, Kranthi Kumar Thallapally, et al. · Chemical Biology Letters · 5

PDF

Synthesis, Characterization, and Antibacterial Activity of Novel 2,3-Dihydroxyquinoxaline-5-сarboxamide Derivatives

2023 · Keesari Srinivas, Puttapaka Vijay Kumar, et al. · Russian Journal of Bioorganic Chemistry · 5

Works count: 56

Citation count: 523

H-index: 12

I10-index: 18